Form 8-K

8-K — Tenon Medical, Inc.

Accession: 0001213900-26-081438

Filed: 2026-07-24

Period: 2026-07-23

CIK: 0001560293

SIC: 3841 (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Item: Submission of Matters to a Vote of Security Holders

Documents

8-K — ea0299237-8k_tenon.htm (Primary)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0299237-8k_tenon.htm · Sequence: 1

false

0001560293

2026-07-23

0001560293

TNON:CommonStockParValue0.001PerShareMember

2026-07-23

0001560293

TNON:WarrantsMember

2026-07-23

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d)

THE SECURITIES EXCHANGE ACT OF 1934

Date

of Report (Date of earliest event reported):

July

23, 2026

TENON MEDICAL, INC.

(Exact

name of registrant as specified in its charter)

Delaware

001-41364

45-5574718

(State or other jurisdiction

(Commission File Number)

(IRS Employer

of incorporation)

Identification No.)

104 Cooper Court

Los Gatos, CA

95032

(Address of principal executive

offices)

(Zip Code)

(408)

649-5760

(Registrant’s

telephone number, including area code)

N/A

(Former

name or former address, if changed since last report.)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions (see General Instruction A.2. below):

☐

Written communications

pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant

to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications

pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications

pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common Stock, par value $0.001 per share

TNON

The Nasdaq Stock Market

LLC

Warrants

TNONW

The Nasdaq Stock Market

LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

Growth Company ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

5.07 Submission of Matters to a Vote of Security Holders.

Tenon

Medical, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) virtually on

July 23, 2026. The record date for the Annual Meeting was June 8, 2026 (the “Record Date”), and the notice of the Annual

Meeting and related proxy materials were mailed to stockholders of record as of the Record Date on or about June 23, 2026.

of the Record Date, the Company had 11,849,674 shares of common stock outstanding representing 11,849,674 votes, 204,159 shares of Series

A Preferred Stock outstanding representing 255,184 votes, and 86,454 shares of Series B Preferred Stock outstanding representing 108,074

votes. At the Annual Meeting, the holders of 6,471,472 shares of the Company’s voting stock, representing 52.98% votes, were present

online or represented by proxy, constituting at least 33 1/3% of the outstanding shares of the Company’s voting stock entitled

to vote and therefore a quorum under Delaware law and the Company’s Bylaws.

There

were six matters submitted to a vote of stockholders at the Annual Meeting and the final voting results were as follows:

Election of the seven

(7) nominees to the Board of Directors of the Company:

Name

Votes For

Withheld

Broker

Non-Votes

Richard Ferrari

3,687,209

1,129,497

1,654,766

Steven Foster

4,105,114

711,592

1,654,766

Richard Ginn

3,468,650

1,348,056

1,654,766

Stephen Hochschuler, MD

4,163,792

652,914

1,654,766

Ivan Howard

3,686,753

1,129,953

1,654,766

Kristine Jacques

3,783,904

1,032,802

1,654,766

Robert Weigle

3,525,337

1,291,369

1,654,766

Each

director nominee was elected to serve as a director until the Company’s 2026 annual meeting of stockholders, or until such person’s

successor is duly elected and qualified, or until such person’s earlier resignation, death or removal. Because directors are elected

by a plurality of the votes cast, votes could only be cast in favor of or withheld from the nominees and thus votes against were not

applicable.

Ratification of the

Audit Committee’s appointment of Haskell & Whitee LLP as the Company’s independent registered public accounting firm

for the fiscal year ending December 31, 2026 (the “Auditor Appointment Proposal”).

Votes

For

Votes

Against

Abstentions

Broker

Non-Votes

5,795,018

149,616

526,838

The

affirmative vote of the holders of a majority of the shares represented at the Annual Meeting and entitled to vote was required for approval

of the Auditor Appointment Proposal. The proposal was approved.

Approval of the Company’s

Second Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s issued and

outstanding common stock at a ratio within the range from one-for-two (1:2) to one-for-thirty-five (1:35), with the final ratio

to be determined by the Board of Directors of the Company in its sole discretion (the “Reverse Stock Split Proposal”).

Votes

For

Votes

Against

Abstentions

Broker

Non-Votes

4,583,877

1,723,195

164,400

The

affirmative vote of the holders of a majority of the shares represented at the Annual Meeting and entitled to vote was required for approval

of the Reverse Stock Split Proposal. The proposal was approved.

4. Approval,

for purposes of complying with Nasdaq Listing Rule 5636(d), of the issuance of shares of common stock underlying convertible promissory

notes issued by the Company in the debt financing consummated on March 11, 2026, which issuance may exceed 19.99% of the Company’s

outstanding shares of common stock as of March 11, 2026 (the “Debt Financing Proposal”).

Votes

For

Votes

Against

Abstentions

Broker

Non-Votes

3,742,855

1,005,184

68,667

1,654,766

The

affirmative vote of the holders of a majority of the shares represented at the Annual Meeting and entitled to vote was required for approval

of the Debt Financing Proposal. The proposal was approved.

5. Approval,

for purposes of Nasdaq Listing Rule 5635(d), of any 20% Issuance (as defined in the proxy statement) made by the Company that is priced

less than the Minimum Price (as defined in the proxy statement) and is within the Nasdaq Parameters described in the Company’s

proxy statement for the Annual Meeting (the “Future Financings Proposal”).

Votes

For

Votes

Against

Abstentions

Broker

Non-Votes

3,653,331

1,080,498

82,877

1,654,766

The

affirmative vote of the holders of a majority of the shares represented at the Annual meeting and entitled to vote was required for approval

of the Future Financing Proposal. The proposal was approved.

6. Approval

of the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there were insufficient votes

at the time of the Annual Meeting to approve one or more of the other proposals (the “Adjournment Proposal”).

Votes

For

Votes

Against

Abstentions

Broker

Non-Votes

4,930,518

1,333,040

207,914

The

affirmative vote of the holders of a majority of the shares represented at the Annual Meeting and entitled to vote was required for approval

of Adjournment Proposal. The proposal was approved.

SIGNATURES

Pursuant

to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

Date: July 24, 2026

Tenon Medical,

Inc.

By:

/s/

Steven M. Foster

Name:

Steven M. Foster

Title:

Chief Executive Officer

and President

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Jul. 23, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 23, 2026

Entity File Number

001-41364

Entity Registrant Name

TENON MEDICAL, INC.

Entity Central Index Key

0001560293

Entity Tax Identification Number

45-5574718

Entity Incorporation, State or Country Code

Entity Address, Address Line One

104 Cooper Court

Entity Address, City or Town

Los Gatos

Entity Address, State or Province

Entity Address, Postal Zip Code

95032

City Area Code

408

Local Phone Number

649-5760

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Common Stock, par value $0.001 per share

Title of 12(b) Security

Common Stock, par value $0.001 per share

Trading Symbol

TNON

Security Exchange Name

NASDAQ

Warrants

Title of 12(b) Security

Warrants

Trading Symbol

TNONW

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=TNON_CommonStockParValue0.001PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=TNON_WarrantsMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: